has_radio_last_6_months
- Coding system
- OPCS-4
- Coding system release
- unknown
- Organisation
- QCovid
- Codelist ID
- qcovid/has_radio_last_6_months
- Version ID
- 6732f71c
Versions
- 6732f71c
Description
OPCS codelist for the has_radio_last_6_months group in the QCovid® to develop the
COVID-19 Population Risk Assessment.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| A613 | Radiotherapy to lesion of peripheral nerve |
| C395 | Radiotherapy to lesion of conjunctiva |
| C823 | External beam radiotherapy to lesion of retina |
| C824 | Plaque radiotherapy to lesion of retina |
| J123 | Selective internal radiotherapy with microspheres to lesion of liver |
| M706 | Radioactive seed implantation into prostate |
| M712 | Implantation of radioactive substance into prostate |
| P205 | Implantation of radioactive substance into vagina |
| Q151 | Introduction of radioactive substance into uterine cavity |
| X65 | Radiotherapy delivery |
| X651 | Delivery of a fraction of total body irradiation |
| X652 | Delivery of a fraction of intracavitary radiotherapy |
| X653 | Delivery of a fraction of interstitial radiotherapy |
| X654 | Delivery of a fraction of external beam radiotherapy NEC |
| X655 | Oral delivery of radiotherapy for thyroid ablation |
| X656 | Delivery of a fraction of intraluminal brachytherapy |
| X657 | Delivery of radionuclide therapy NEC |
| X658 | Other specified radiotherapy delivery |
| X659 | Unspecified radiotherapy delivery |
| Y35 | Introduction of removable radioactive material into organ NOC |
| Y351 | Introduction of radioactive caesium into organ NOC |
| Y352 | Introduction of iridium wire into organ NOC |
| Y353 | Introduction of radium into organ NOC |
| Y354 | Introduction of radioactive substance into organ for brachytherapy NOC |
| Y358 | Other specified introduction of removable radioactive material into organ NOC |
| Y359 | Unspecified introduction of removable radioactive material into organ NOC |
| Y36 | Introduction of non-removable material into organ NOC |
| Y361 | Introduction of gold seeds into organ NOC |
| Y362 | Introduction of therapeutic implant into organ NOC |
| Y363 | Radioactive seed implantation NOC |
| Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC |
| Y368 | Other specified introduction of non-removable material into organ NOC |
| Y369 | Unspecified introduction of non-removable material into organ NOC |
| Y91 | External beam radiotherapy |
| Y911 | Megavoltage treatment for complex radiotherapy |
| Y912 | Megavoltage treatment for simple radiotherapy |
| Y913 | Superficial or orthovoltage treatment for radiotherapy |
| Y914 | Megavoltage treatment for adaptive radiotherapy |
| Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy |
| Y918 | Other specified external beam radiotherapy |
| Y919 | Unspecified external beam radiotherapy |
| A613 | Radiotherapy to lesion of peripheral nerve |
| C395 | Radiotherapy to lesion of conjunctiva |
| C823 | External beam radiotherapy to lesion of retina |
| C824 | Plaque radiotherapy to lesion of retina |
| J123 | Selective internal radiotherapy with microspheres to lesion of liver |
| M706 | Radioactive seed implantation into prostate |
| M712 | Implantation of radioactive substance into prostate |
| P205 | Implantation of radioactive substance into vagina |
| Q151 | Introduction of radioactive substance into uterine cavity |
| X65 | Radiotherapy delivery |
| X651 | Delivery of a fraction of total body irradiation |
| X652 | Delivery of a fraction of intracavitary radiotherapy |
| X653 | Delivery of a fraction of interstitial radiotherapy |
| X654 | Delivery of a fraction of external beam radiotherapy NEC |
| X655 | Oral delivery of radiotherapy for thyroid ablation |
| X656 | Delivery of a fraction of intraluminal brachytherapy |
| X657 | Delivery of radionuclide therapy NEC |
| X658 | Other specified radiotherapy delivery |
| X659 | Unspecified radiotherapy delivery |
| Y35 | Introduction of removable radioactive material into organ NOC |
| Y351 | Introduction of radioactive caesium into organ NOC |
| Y352 | Introduction of iridium wire into organ NOC |
| Y353 | Introduction of radium into organ NOC |
| Y354 | Introduction of radioactive substance into organ for brachytherapy NOC |
| Y358 | Other specified introduction of removable radioactive material into organ NOC |
| Y359 | Unspecified introduction of removable radioactive material into organ NOC |
| Y36 | Introduction of non-removable material into organ NOC |
| Y361 | Introduction of gold seeds into organ NOC |
| Y362 | Introduction of therapeutic implant into organ NOC |
| Y363 | Radioactive seed implantation NOC |
| Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC |
| Y368 | Other specified introduction of non-removable material into organ NOC |
| Y369 | Unspecified introduction of non-removable material into organ NOC |
| Y91 | External beam radiotherapy |
| Y911 | Megavoltage treatment for complex radiotherapy |
| Y912 | Megavoltage treatment for simple radiotherapy |
| Y913 | Superficial or orthovoltage treatment for radiotherapy |
| Y914 | Megavoltage treatment for adaptive radiotherapy |
| Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy |
| Y918 | Other specified external beam radiotherapy |
| Y919 | Unspecified external beam radiotherapy |